Boston Scientific Corp (BSX) Stock Forecast
US · Healthcare
Current price
$44.20
Market cap
$65.70B
Mean price target
$75.00
Implied upside
69.7%
Key takeaways
- Analysts rate Boston Scientific Corp a “Buy”, with a mean price target of $75.00 — about 69.7% upside from the current $44.20, based on 29 analysts.
- BSX is trading near its 52-week low, at 0% of the $43.89–$109.50 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 29 |
| Mean target | $75.00 |
| High target | $106.00 |
| Low target | $55.00 |
| Rating split (SB / B / H / S / SS) | 10 / 24 / 0 / 0 / 0 |
Price & trading
| Current price | $44.20 |
|---|---|
| Previous close | $44.46 |
| 52-week high | $109.50 |
| 52-week low | $43.89 |
| 50-day average | $53.88 |
| Beta | 0.56 |
See the full BSX breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Boston Scientific Corp (BSX) share price?
- Boston Scientific Corp last traded at $44.20 with a market capitalisation of about $65.7B.
- What is the analyst price target for BSX?
- The mean analyst price target for Boston Scientific Corp is $75.00, roughly 69.7% above the latest price. The current consensus rating is “Buy”.
- Where can I see Boston Scientific Corp's full financial metrics?
- Luminoso tracks BSX's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.